Timing Is Not a Detail. It Is the Protocol..
Most peptide guides treat timing as an afterthought: "take BPC-157 twice daily." But your hormonal environment changes dramatically across a 24-hour cycle, and peptide effectiveness is directly influenced by when you administer relative to those rhythms.
Growth hormone peaks during deep sleep. Cortisol peaks at 6-8 AM. Insulin sensitivity is highest in the morning and lowest at night. Testosterone production concentrates during sleep. AMPK activity follows circadian patterns.
Aligning peptide administration with these biological windows—rather than treating timing as arbitrary—is the difference between a good protocol and an optimized one.
The Morning Window (5-8 AM).
MOTS-C: Morning administration aligns with peak AMPK sensitivity and natural metabolic activity. Fasted morning dosing (before breakfast) maximizes the metabolic signaling window. 1-2 mg subcutaneous upon waking.
Semax: BDNF and dopamine modulation for cognitive performance peaks when administered in the morning. 200-300 mcg intranasal at 5-6 AM provides the full-day cognitive benefit. Onset is 15-30 minutes.
BPC-157 (first dose): Morning subcutaneous injection establishes the first tissue concentration peak. Near the injury site if targeting a specific area. 250-500 mcg.
CJC-1295/Ipamorelin: If you are running a morning dosing schedule (some prefer this to bedtime), administer on an empty stomach at least 30 minutes before eating. However, bedtime dosing is generally preferred for GH secretagogues.
What NOT to take in the morning: DSIP (sleep peptide—evening only). Selank can be morning but often better reserved for afternoon stress management.
The Afternoon Window (12-4 PM).
BPC-157 (second dose if twice daily): 250-500 mcg subcutaneous. Maintains tissue concentration through the afternoon and evening.
Selank: Afternoon intranasal dosing (250-500 mcg) targets the stress accumulation that builds through the workday. GABA modulation counteracts the cortisol rise that impairs afternoon cognitive function.
Semax (second dose if splitting): If running 400-600 mcg daily, the second intranasal dose in early afternoon extends the cognitive benefit without interfering with evening wind-down.
Avoid: GH secretagogues in the afternoon. They work by amplifying pulsatile GH release, which is minimal during daytime hours. Save them for bedtime.
The Evening Window (6-10 PM).
CJC-1295/Ipamorelin: 100-300 mcg subcutaneous on an empty stomach, 30-60 minutes before bed. This amplifies the natural nocturnal GH pulse that occurs during the first cycle of deep sleep. Do not eat within 2 hours of dosing—insulin blunts GH release.
DSIP: 100-250 mcg subcutaneous 30-45 minutes before your target sleep time. Promotes delta wave sleep architecture regardless of when your sleep window falls.
Epitalon: Evening dosing (5-10 mg subcutaneous) aligns with the pineal gland's nighttime melatonin production cycle. During 10-20 day Epitalon cycles, consistent evening dosing maximizes the melatonin restoration effect.
Selank (if needed): A small evening dose (250 mcg intranasal) can support the transition from high-cortisol workday to parasympathetic recovery, improving sleep onset.
GHK-Cu: Can be dosed any time, but evening administration allows the repair processes to operate during the sleep window when growth hormone is active and cortisol is low.
Fasting Compatibility.
Fasting-compatible (will not break a fast): All subcutaneous peptides (BPC-157, TB-500, GHK-Cu, MOTS-C, DSIP, CJC-1295/Ipamorelin). Subcutaneous injection does not trigger insulin or digestive processes.
Fasting-compatible intranasal: Semax, Selank. Intranasal absorption bypasses the GI tract entirely.
May affect fasting: Oral BPC-157 (ingested, enters the GI tract). The caloric content is negligible, but purists may prefer dosing at the end of the eating window. For practical purposes, oral BPC-157 does not meaningfully break a fast.
Critical for GH secretagogues: Do not eat within 2 hours before CJC-1295/Ipamorelin dosing. Insulin from food blunts GH release. This is the one timing rule that materially affects outcomes.
For men running intermittent fasting (16:8 or 20:4): Subcutaneous peptides during the fasting window are fine. Schedule GH secretagogues before bed on an empty stomach. Time oral BPC-157 within the eating window if using for gut protection.
The Complete Daily Schedule.
5:00 AM — Wake: MOTS-C 1 mg subcutaneous (fasted). Semax 200 mcg intranasal.
5:30 AM — Morning routine: BPC-157 250 mcg subcutaneous (near target area).
7:00 AM — First meal (if eating): Oral BPC-157 250 mcg if using for gut protection.
1:00 PM — Afternoon: Selank 250 mcg intranasal. BPC-157 250 mcg subcutaneous (second dose).
9:00 PM — Pre-sleep: CJC-1295/Ipamorelin 200 mcg subcutaneous (empty stomach, no food since 7 PM). DSIP 150 mcg subcutaneous. GHK-Cu 1 mg subcutaneous.
During 10-day Epitalon cycles: Add Epitalon 5-10 mg subcutaneous at 9 PM.
TB-500: 2 mg subcutaneous twice weekly, timing flexible. Many prefer morning dosing on training days.
This is the maximum protocol. Most men run 2-3 compounds at a time. Extract the timing principles for your specific stack.
◆ Key Takeaway
MOTS-C and Semax in the morning (metabolic and cognitive windows). BPC-157 twice daily for sustained tissue concentration. Selank afternoon for stress management. GH secretagogues and DSIP before bed on an empty stomach. Epitalon evenings during cycles. Subcutaneous peptides are fasting-compatible. GH secretagogues require 2+ hours fasted before dosing.